Loading market dashboard
2seventy bio, Inc.
TSVTHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
2seventy bio, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $87.70M | $64.44M - $111.29M | -$79.45M | $0.29 | 1 |
| Dec 2028 | $84.11M | $61.81M - $106.75M | -$76.20M | $0.255 | 1 |
| Dec 2027 | $79.34M | $58.30M - $100.70M | -$71.88M | $0.18 | 1 |
| Dec 2026 | $75.12M | $55.20M - $95.33M | -$68.05M | -$0.148 | 3 |
| Dec 2025 | $68.48M | $54.50M - $77.41M | -$62.04M | -$0.40 | 3 |
| Dec 2024 | $49.90M | $44.73M - $53.35M | -$45.21M | -$0.84 | 3 |
| Dec 2023 | $44.12M | $32.42M - $55.99M | -$39.97M | -$3.021 | 2 |
| Dec 2022 | $49.84M | $39.25M - $59.33M | -$45.16M | -$7.789 | 2 |